| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 31/05/2024 | 22:33 | GlobeNewswire Inc. | Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 23/05/2024 | 22:56 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 23/05/2024 | 22:54 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 23/05/2024 | 21:00 | GlobeNewswire Inc. | Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 21/05/2024 | 14:00 | GlobeNewswire Inc. | Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024 | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 13/05/2024 | 23:01 | GlobeNewswire Inc. | Guardion Health Sciences Announces | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 13/05/2024 | 22:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 06/05/2024 | 22:01 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 06/05/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 29/03/2024 | 11:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 06/02/2024 | 16:19 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 31/01/2024 | 23:21 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 31/01/2024 | 00:13 | GlobeNewswire Inc. | Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc. | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 13/11/2023 | 22:10 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 14/08/2023 | 14:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 08/08/2023 | 02:47 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 05/07/2023 | 23:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 16/06/2023 | 23:02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 05/06/2023 | 23:09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 30/05/2023 | 14:00 | GlobeNewswire Inc. | Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 15/05/2023 | 14:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 15/05/2023 | 14:01 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 17/04/2023 | 14:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022 | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 17/04/2023 | 14:01 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 06/03/2023 | 14:00 | GlobeNewswire Inc. | Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 08/02/2023 | 21:05 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 24/01/2023 | 22:05 | GlobeNewswire Inc. | Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 11/01/2023 | 23:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 06/01/2023 | 22:15 | GlobeNewswire Inc. | Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
| 12/12/2022 | 23:16 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:GHSI | Guardion Health Sciences Inc |